Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.